NAD+ pathways are an active area of research, but the effects of giving it by injection or IV are not yet well established. Some claim benefits for aging, addiction or mood, but the evidence is lacking, and it cannot replace proven treatments.
Studies show that NAD+ levels fall with age in several tissues, which is why ways to raise NAD+ are being studied. Clinical trials show that oral precursors (NMN, NR) raise blood NAD+ levels, but results are mixed on whether fatigue, muscle strength or markers of aging improve. Research on intravenous NAD+ in people remains small in scale.